Literature DB >> 12412615

High-dose antithrombin therapy for sepsis: mechanisms of action.

Toshiaki Iba1, Akio Kidokoro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12412615     DOI： 10.1097/00024382-200211000-00001

Source DB:  PubMed          Journal:  Shock        ISSN： 1073-2322            Impact factor:   3.454


× No keyword cloud information.
  9 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients.

Authors:  Jessica C Cardenas; Yao-Wei Wang; Jay V Karri; Seenya Vincent; Andrew P Cap; Bryan A Cotton; Charles E Wade
Journal:  Thromb Res       Date:  2020-01-15       Impact factor: 3.944

Review 3.  Anticoagulant modulation of inflammation in severe sepsis.

Authors:  Karen S Allen; Eva Sawheny; Gary T Kinasewitz
Journal:  World J Crit Care Med       Date:  2015-05-04

4.  Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin.

Authors:  Toshiaki Iba; Akio Kidokoro; Masaki Fukunaga; Kunihiko Nagakari; Masaru Suda; Seiichiro Yoshikawa; Yukiko Ida
Journal:  Intensive Care Med       Date:  2005-07-02       Impact factor: 17.440

5.  The effect of Antithrombin-III on routine hematological and biochemical parameters in an experimental animal model of skeletal muscle ischemia-reperfusion injury.

Authors:  Dg Karamanos; Cd Karkos; Ag Kambaroudis; M Kritsepi; S Papadopoulos; Ct Spyridis; Ts Gerassimidis
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

Review 6.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31

Review 7.  To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Semin Thromb Hemost       Date:  2017-08-04       Impact factor: 4.180

8.  Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model.

Authors:  Toshiaki Iba; Etsuro Nakarai; Toshio Takayama; Kenji Nakajima; Tetsumasa Sasaoka; Yoichi Ohno
Journal:  Crit Care       Date:  2009-12-14       Impact factor: 9.097

9.  Antithrombin effect on coagulation and fibrinolytic profiles after living donor liver transplantation: a pilot study.

Authors:  J Kaneko; Y Sugawara; S Tamura; J Togashi; Y Matsui; M Makuuchi
Journal:  Int J Lab Hematol       Date:  2008-12-08       Impact factor: 2.877
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.